506 related articles for article (PubMed ID: 26951240)
1. Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.
Sivanandan S; Agarwal R
Paediatr Drugs; 2016 Apr; 18(2):123-38. PubMed ID: 26951240
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
[TBL] [Abstract][Full Text] [Related]
6. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.
Mitra S; de Boode WP; Weisz DE; Shah PS
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013588. PubMed ID: 37039501
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
8. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2013 Apr; (4):CD003481. PubMed ID: 23633310
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Shah SS; Ohlsson A
Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Shah SS; Ohlsson A
Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2010 Apr; (4):CD003481. PubMed ID: 20393936
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
[TBL] [Abstract][Full Text] [Related]
14. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
15. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
Sekar KC; Corff KE
J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
[TBL] [Abstract][Full Text] [Related]
18. Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.
Mitra S; Florez ID; Tamayo ME; Mbuagbaw L; Vanniyasingam T; Veroniki AA; Zea AM; Zhang Y; Sadeghirad B; Thabane L
JAMA; 2018 Mar; 319(12):1221-1238. PubMed ID: 29584842
[TBL] [Abstract][Full Text] [Related]
19. Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know.
Mercanti I; Ligi I; Boubred F; Grandvuillemin I; Buffat C; Fayol L; Millet V; Simeoni U
Curr Pharm Des; 2012; 18(21):3007-18. PubMed ID: 22564295
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
Gouyon JB; Kibleur Y
Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
